---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-065828"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2026-06-05T20:19:29+00:00"
generated_at: "2026-06-05T20:31:55.283406+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Unicycive raises ATM capacity to $150M; files new $50M shelf registration

## Summary
- Entered Amendment No. 2 to Sales Agreement with Guggenheim Securities on June 5, 2026.
- ATM offering capacity increased from $100M to $150M in aggregate offering price.
- Also filed a new S-3 registration statement to sell an additional $50M of common stock.
- Previous agreements: initial Sales Agreement Nov 13, 2024; Amendment No. 1 Nov 14, 2025.

## SEC filing metadata
- accession: 0001213900-26-065828
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2026-06-05T20:19:29+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/0001213900-26-065828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/ea0291976-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-065828
- JSON: https://secwatch.observer/filing/0001213900-26-065828.json
- Plain text: https://secwatch.observer/filing/0001213900-26-065828.txt

## Key facts
- Material Agreements
  Unicycive Therapeutics, Inc. amended Amendment No. 2 to the Sales Agreement with Guggenheim Securities, LLC (effective 2026-06-05).
  - Action: amendment
  - Agreement: atm program
  - Counterparty: Guggenheim Securities, LLC
  - Effective: 2026-06-05
  source text: On June 5, 2026, the Company entered into Amendment No. 2 to the Sales Agreement with the Agent (the “Amendment”) to increase the number of Shares that may be sold in the ATM Offering to $150,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/0001213900-26-065828-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
